You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
明德生物(002932.SZ)收到換髮的醫療器械生產許可證
格隆匯 10-21 15:56

格隆匯10月21日丨明德生物(002932.SZ)公佈,公司於2019年8月22日和2019年9月10日分別召開了第二屆董事會第二十六次會議和2019年第一次臨時股東大會,審議通過了《關於變更公司經營範圍及住所並修訂公司章程的議案》。2019年9月20日,公司完成了工商變更登記及《公司章程》備案手續,並取得了由武漢市市場監督管理局核發的《營業執照》。

基於公司住所及經營範圍發生了變更,公司收到了湖北省食品藥品監督管理局於2019年10月16日換髮的《醫療器械生產許可證》,許可證編號:鄂食藥監械生產許20120393號。

變更前:住所為武漢市東湖開發區關東科技園東信路特1號留學生創業園E棟2樓;生產範圍為二類:6840臨牀檢驗分析儀器及體外診斷試劑;6821醫用電子儀器設備。

變更後:住所為武漢東湖新技術開發區高新二路388號武漢光谷國際生物醫藥企業加速器3.1期25棟1層(3)廠房三號;生產範圍為二類、三類:6840臨牀檢驗分析儀器及體外診斷試劑;二類:6821醫用電子儀器設備;二類:22-04免疫分析設備、21-03數據處理軟件、22-03電解質及血氣分析設備。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account